5-Nitroindole
Based on 1 Customer Validation
5-Nitroindole is a mutagenic nitroarene and universal base analog. 5-Nitroindole significantly reduces the cellular adenylate energy charge by decreasing ATP levels and increasing AMP levels. 5-Nitroindole inhibits lipid peroxidation.
For research use only. We do not sell to patients.
- Purity : 98.90%
- CAS No.: 6146-52-7
- Formula: C8H6N2O2
- Molecular Weight:162.15
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
In Vitro
5-Nitroindole (25-100 μM; 0-4 h) decreases the adenylate energy charge of rat hepatocytes significantly by reducing ATP levels and increasing AMP levels[1].
5-Nitroindole (50-100 μM; 15-60 min) inhibits NADPH-dependent and t-BuOOH-dependent lipid peroxidation in liver microsomes, and NADH-initiated lipid peroxidation in mitochondria[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 6146-52-7
-
Appearance Solid
-
Molecular Weight 162.15
-
Formula C8H6N2O2
-
Color Yellow to green
-
SMILES
O=[N+]([O-])C1=CC2=C(NC=C2)C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
DMSO : 100 mg/mL (616.71 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
Purity & Documentation
-
Data Sheet (273 KB)
-
SDS (614 KB)
- English - EN (614 KB)
- Français - FR (614 KB)
- Deutsch - DE (614 KB)
- Norwegian - NO (614 KB)
- Español - ES (614 KB)
- Swedish - SV (614 KB)
- Italian - IT (614 KB)
- Korean - KR (614 KB)
- Portuguese - PT (614 KB)
-
Handling Instructions (2659 KB)
References
[1]. Dubin M, et al. Effect of 5-nitroindole on adenylate energy charge, oxidative phosphorylation, and lipid peroxidation in rat hepatocytes. Biochem Pharmacol. 1994 Oct 7;48(7):1483-92. [Content Brief]
[2]. Loakes D, et al. 5-Nitroindole as an universal base analogue. Nucleic Acids Res. 1994 Oct 11;22(20):4039-43. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 6.1671 mL | 30.8356 mL | 61.6713 mL | 154.1782 mL |
| 5 mM | 1.2334 mL | 6.1671 mL | 12.3343 mL | 30.8356 mL | |
| 10 mM | 0.6167 mL | 3.0836 mL | 6.1671 mL | 15.4178 mL | |
| 15 mM | 0.4111 mL | 2.0557 mL | 4.1114 mL | 10.2785 mL | |
| 20 mM | 0.3084 mL | 1.5418 mL | 3.0836 mL | 7.7089 mL | |
| 25 mM | 0.2467 mL | 1.2334 mL | 2.4669 mL | 6.1671 mL | |
| 30 mM | 0.2056 mL | 1.0279 mL | 2.0557 mL | 5.1393 mL | |
| 40 mM | 0.1542 mL | 0.7709 mL | 1.5418 mL | 3.8545 mL | |
| 50 mM | 0.1233 mL | 0.6167 mL | 1.2334 mL | 3.0836 mL | |
| 60 mM | 0.1028 mL | 0.5139 mL | 1.0279 mL | 2.5696 mL | |
| 80 mM | 0.0771 mL | 0.3854 mL | 0.7709 mL | 1.9272 mL | |
| 100 mM | 0.0617 mL | 0.3084 mL | 0.6167 mL | 1.5418 mL |